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I N T R O D U C T I O N
In humans, members of the SLC13 transporter family 
catalyze the transport of dicarboxylic and tricarboxylic 
acids, as well as sulfate, across the plasma membrane, 
fulilling several physiological and pathophysiological 
roles (Bergeron et al., 2013). Citrate plays a major role 
in determining the metabolic status of the cell by acting 
as a key precursor and allosteric regulator of fatty acid 
synthesis (Spencer and Lowenstein, 1962), and by down-
regulating both fatty acid -oxidation and glycolysis 
(Garland et al., 1963; Denton and Randle, 1966; Ruderman 
et al., 1999). NaDC1 (SLC13A2) is found on the apical 
membranes of renal proximal tubule and appears to be 
important for the regulation of urinary citrate and the 
prevention of kidney stones (Ho et al., 2007), whereas 
its high afinity homologue, NaDC3 (SLC13A3), has a 
wide tissue distribution (Pajor, 2014). NaCT (SLC13A5) 
is responsible, in part, for the uptake of citrate into the 
cytosol of liver cells (Inoue et al., 2002b,c). Remarkably, 
deletion of NaCT in mice leads to protection against 
adiposity and insulin resistance, highlighting the inte-
gral role of these transporters to normal metabolic func-
tion and hinting at therapeutic potential in combating 
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metabolic disease, obesity, and diabetes (Birkenfeld 
et al., 2011). Members of the SLC13 family are 50% 
identical to each other and display distinct functional 
properties. NaCT is primarily a citrate transporter but 
can also transport C4-dicarboxylates such as succinate, 
fumarate, and malate (Inoue et al., 2002b). NaDC1 and 
NaDC3 are C4-dicarboxylate transporters with a low and 
high afinity, respectively, but also retain the ability to 
transport citrate (Pajor, 1995; Pajor and Sun, 1996, 2000; 
Kekuda et al., 1999; Oshiro and Pajor, 2005). Two other 
SLC13 members (NaS1 [SLC13A1] and NaS2 [SLC13A4]) 
transport, among other compounds, divalent anions sul-
fate and selenate (Busch et al., 1994; Markovich et al., 
2005). Despite differences in substrate afinity and spec-
iicity, all ive SLC13 members couple the electrogenic 
transport of their respective substrates to the transport 
of multiple Na+ ions.
The SLC13 transporters belong to a larger group of 
related transporters called the divalent anion:Na+ sym-
porter (DASS) family (Transporter Classiication Database 
no. 2.A.47) (Saier et al., 2006). Knockdown of a gene 
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746 Functional characterization of VcINDY
regarding its transport stoichiometry, the extent of its 
substrate selectivity, and its ion coupling.
Here, we address these functional questions for VcINDY 
by assaying the puriied protein reconstituted into lipo-
somes. Measuring transport activity using proteolipo-
somes has several advantages over using whole cells or 
membrane vesicles. In proteoliposomes, the protein of 
interest can be reconstituted in isolation, eliminating 
the possibility of artifacts caused by native transport 
activity in the bacterial cell or by interactions with en-
dogenous bacterial proteins (Chen and Wilson, 1986; 
Quick et al., 2006; Hall and Pajor, 2007). In addition, 
unlike cells, the reconstituted system provides complete 
control of both external and internal solutions, and sub-
strate catabolism is not a problem. Collectively, these 
features make the puriied, reconstituted system an ideal 
setting for precise functional characterization of bacterial 
transporter proteins. Using this experimental approach, 
we demonstrate that VcINDY is a Na+ gradient–dependent, 
electrogenic, pH gradient–independent C4-dicarbox-
ylate transporter with characteristics most similar to its 
mammalian homologue, NaDC3, the high afinity dicar-
boxylate transporter. These results are essential for 
further analysis of the transporter’s mechanism and for 
initiating computational studies of VcINDY.
M A T E R I A L S  A N D  M E T H O D S
Expression and puriication
VcINDY was expressed and puriied essentially as described previ-
ously (Mancusso et al., 2012). BL21-AI (Life Technologies) was 
transformed with pEThisINDY (a modiied pET vector [Love et al., 
2010] harboring the gene encoding VcINDY with an N-terminal 
deca-histidine tag) and grown in LB supplemented with 100 µg/ml 
kanamycin to A600 of 0.6, at which point expression was induced by 
the addition of 0.1 M IPTG and 6.6 mM (0.1% wt/vol) l-arabinose. 
Cultures were incubated overnight at 19°C and then harvested 
and lysed using a homogenizer (EmulsiFlex-C3; Avestin), and 
the membrane fraction was isolated by ultracentrifugation. This 
membrane fraction was resuspended in buffer containing 50 mM 
Tris HCl, pH 8, 100 mM NaCl, and 5% (vol/vol) glycerol. Pro-
tein was extracted from the membranes by the addition of n-
dodecyl--d-maltoside (DDM; Anatrace) to a inal concentration 
of 20 mM. Insoluble material was removed by ultracentrifuga-
tion, and the detergent-solubilized fraction was incubated with 
Talon metal afinity resin (Takara Bio Inc.) overnight at 4°C. 
The resin was washed, irst with 20 column volumes (CV) of the 
above buffer supplemented with 2 mM DDM and 10 mM imidaz-
ole, and then with 20 CV of the same buffer supplemented with 
2 mM DDM and 20 mM imidazole. Bound protein was eluted by 
the addition of buffer containing 300 mM imidazole. The histi-
dine tag was removed by incubation with his-tagged TEV prote-
ase overnight at 4°C. The TEV protease and uncleaved protein 
were removed by reapplying the sample to Talon resin. The pro-
tein not sequestered by the resin was collected, concentrated, 
and exchanged into buffer containing 50 mM Tris/HEPES, 
pH 7.5, 150 mM NaCl, 5% glycerol, and 3 mM decyl--d-maltoside 
(DM; Anatrace). The protein was either used immediately or 
snap-frozen and stored at 80°C. Protein concentration was cal-
culated using the absorbance at 280 nm and the theoretical ex-
tinction coeficient.
encoding a DASS family member (I’m not dead yet 
[INDY]) in the fruit ly Drosophila melanogaster results 
in reduced fat storage and, interestingly, an extended 
lifespan phenotype, mimicking the effects of caloric re-
striction (Rogina et al., 2000). In contrast to its human 
counterparts, citrate and C4-dicarboxylate transport by 
the ly homologue, DrINDY, is apparently electroneu-
tral and cation independent (Knauf et al., 2002). Sev-
eral bacterial DASS family members (30% identical to 
human SLC13 family members) have also been studied, 
revealing functional characteristics sometimes similar 
but sometimes divergent compared with the human ho-
mologues. However, the similarities are suficient to sug-
gest a comparable architecture and shared basic mode of 
action (Hall and Pajor, 2007; Youn et al., 2008; Strickler 
et al., 2009; Pajor et al., 2013).
Recently, our understanding of the transport mecha-
nism of this family took a signiicant step forward with 
the publication of a high resolution x-ray crystal struc-
ture of VcINDY, a SLC13 homologue from Vibrio cholerae 
(Mancusso et al., 2012) (Fig. 1, A and B). VcINDY is 26–
33% identical to SLC13 family members in amino acid 
sequence and, like other DASS family members, cou-
ples a Na+ gradient to the transport of succinate, a C4-di-
carboxylate, in cell-based assays (Mancusso et al., 2012). 
In these assays, transport of succinate is inhibited by the 
presence of other C4-dicarboxylates, malate and fuma-
rate, suggesting that they may also serve as substrates. 
On the other hand, citrate and glutamate only mildly 
inhibit succinate transport, whereas sulfate has no effect 
(Mancusso et al., 2012). Succinate, malate, and citrate 
also confer thermostability to the detergent-solubilized 
VcINDY protein (Mancusso et al., 2012), suggesting 
that all three compounds interact with the protein. The 
3.2-Å resolution crystal structure of VcINDY reveals a 
homodimeric protein, with each protomer containing 
11 transmembrane helices and 2 reentrant hairpin 
loops, HPIN and HPOUT (Fig. 1, A and B). In each pro-
tomer, conserved residues at the tips of HPIN and HPOUT 
coordinate the bound substrate, likely a single citrate 
molecule, and a single Na+ ion. A second predicted Na+-
binding site lies at the tip of HPOUT, but no Na+ ion is 
detected at this location and the role of this putative 
binding site in Na+ binding and transport has not been 
functionally veriied (Mancusso et al., 2012). Topologi-
cal studies of VcINDY homologues and the location of 
the substrates in the crystal structure suggest that this 
structure of VcINDY represents the inward-facing state 
of the protein (Mancusso et al., 2012) (Fig. 1 A). The 
bound citrate molecule has been proposed to be acting 
as a state-dependent inhibitor, trapping the protein in 
this inward-facing conformation, although there is little 
evidence to support this assertion. The structure and 
cell-based characterization of VcINDY clearly place it as 
a functional representative of the DASS family but leave 
key mechanistic questions unanswered, including those 












For the pH dependence experiments (Fig. 7), transport assays 
were performed as detailed for the typical transport assay. The 
low pH values (pH 4–5) of the solutions were attained using a 
Tris/gluconate-buffering system, and the pH values of the rest 
were set with a Tris/MES-buffering system. For the electrogenicity 
experiment (Fig. 4 B), we set the different voltages across the 
membrane by varying the K+ gradient across the membrane in the 
presence of valinomycin: 120 mV (100 mMIN/1 mMOUT), 50 mV 
(100 mMIN/15 mMOUT), 0 mV (100 mMIN/100 mMOUT), +50 mV 
(15 mMIN/100 mMOUT), and +120 mV (1 mMIN/100 mMOUT). For 
the counterlow assay (Fig. 5), the liposomes were loaded with 
50 mM Tris/HEPES, pH 7.5, 100 mM NaCl, and 1 mM succinate. 
The external solution contained 50 mM Tris/HEPES, pH 7.5, 
100 mM NaCl, 900 nM succinate, and 100 nM [3H]succinate. This 
experiment was also performed in the absence of Na+ ions, in 
which case the NaCl in the above solutions was replaced with ChCl. 
For the citrate dose–response experiment (Fig. 8 C), trisodium 
citrate was used to increase the concentration of citrate in the 
external solution. The Na+ concentration and ionic balance were 
maintained by the addition of NaCl. The osmotic balance of the 
solutions was maintained using sucrose. The percentage of abun-
dance of the various citrate and succinate protonation states was 
calculated using HySS2009 software (Alderighi et al., 1999).
Fluorescent labeling of single-cysteine mutants
To speciically label only internal cysteines (those facing the 
lumen of the liposome), proteoliposomes containing VcINDY 
mutants were irst incubated with the membrane-impermeable 
cysteine-reactive reagent methyl-PEG12-maleimide (MM(PEG)12; 
Thermo Fisher Scientiic) for 20 min at room temperature to 
fully label external cysteine residues. The MM(PEG)12 reaction 
was quenched by the addition of 100 mM l-cysteine. Excess cyste-
ine and MM(PEG)12 were removed by two washing steps in which 
the proteoliposomes were pelleted by centrifugation and resus-
pended in buffer devoid of the unwanted reagents. The proteoli-
posomes were solubilized in 2.6% (wt/vol) DM, and internal 
cysteine residues were luorescently labeled by incubation with 
Alexa Fluor 488 C5 Maleimide (Life Technologies) for 2 h at room 
temperature in a solution comprised of 20 mM Tris/HEPES, 
pH 7.4, 199 mM KCl, and 1 mM NaCl. As a positive control and to 
obtain a “100% labeled” sample, the initial MMPEG12 protection 
step was excluded. Thus, after DM solubilization, all cysteines 
were available to luorescently label. Proteoliposomes were run 
on SDS-PAGE gels, and luorescently labeled protein was visual-
ized by UV transillumination using Fluorchem E (Proteinsimple). 
Equal protein loading was assessed by subsequently staining the 
gels with Coomassie Brilliant Blue dye.
R E S U L T S
Functional reconstitution of VcINDY
To assess the transport characteristics of VcINDY, we pu-
riied the protein, reconstituted it into liposomes, and 
measured its transport characteristics. We puriied de-
tergent-solubilized VcINDY with a single immobilized 
metal afinity chromatography step using the N-terminal 
decahistidine tag (Fig. 1), subsequently removing the 
afinity tag and reconstituting the protein by adding it to 
Triton X-100–destabilized liposomes using the procedure 
Protein reconstitution
Protein was functionally reconstituted into liposomes essentially 
as described previously for the aspartate transporter GltPh (Ryan 
et al., 2009). Lipids, in a ratio of 3:1 Escherichia coli polar lipids to 
POPC (Avanti Polar Lipids, Inc.), were dried and resuspended to 
a concentration of 10 mg/ml in internal solution (the nature of 
the internal solution was dependent on the nature of the transport 
assay; typically, it was 20 mM Tris/HEPES, pH 7.5, 1 mM NaCl, and 
199 mM KCl). After ive freeze–thaw cycles, the lipids were ex-
truded though a 400-nm ilter and titrated with Triton X-100. The 
incorporation of Triton X-100 was monitored using the A540 read-
ing, and additions were stopped after reaching the saturation 
point. Protein was added to the lipids in a ratio of 1.5 µg protein/
mg lipid. The detergent was gradually removed, and proteolipo-
somes were formed by multiple additions of Biobeads SM (Bio-
Rad Laboratories). The proteoliposomes were separated from the 
Biobeads, collected by centrifugation, resuspended to a inal con-
centration of 10 mg/ml lipid with the appropriate lumenal solu-
tion, snap-frozen, and stored at 80°C. If the need arose to 
change the internal solution, the proteoliposomes were collected 
by centrifugation, diluted in the desired solution, freeze-thawed 
three times, and extruded.
Transport assays
Before performing the transport assays, the proteoliposomes were 
extruded through a 400-nm ilter and concentrated to 100 mg/ml 
lipid by centrifugation. A typical transport assay was performed as 
follows. The transport reaction was started by 150-fold dilution of 
the proteoliposomes into appropriate reaction solution warmed 
to 30°C. The reaction solution varied depending on the experi-
ment (see below for details), but for a typical transport assay, this 
solution consisted of 20 mM Tris/HEPES, pH 7.5, 100 mM KCl, 
100 mM NaCl, 1 µM valinomycin, and 1 µM [3H]succinate (Amer-
ican Radiolabeled Chemicals). For all transport assays performed, 
at each time point a 0.2-ml sample was taken and diluted 10-fold 
in ice-cold quench buffer consisting of 20 mM Tris/HEPES, pH 7.5, 
and 200 mM choline chloride (ChCl). The quenched reaction 
was then subjected to rapid iltration over a nitrocellulose mem-
brane (0.22 µm; EMD Millipore), and the ilters were washed with 
3 ml of quench buffer. Each ilter was dissolved in a liquid scintil-
lation cocktail (FilterCount; PerkinElmer), and associated radioac-
tivity was counted using a Trilux  counter (PerkinElmer). Initial 
transport rates were calculated using a linear it to three points 
in the irst minute of the transport reaction.
The composition of the solutions was changed depending on 
the requirements of the experiment. In the cation dependence 
experiment (Fig. 2), valinomycin was omitted and the Na+ in the 
internal and external solutions was replaced with LiCl or KCl. 
ChCl was used to maintain the ionic and osmotic balance of the 
solutions. In the Na+ dose–response experiment (Fig. 3), the inter-
nal solution contained 20 mM Tris/HEPES, pH 7.5, 1 mM NaCl, 
200 mM KCl, and 99 mM ChCl. The external solution consisted of 
20 mM Tris/HEPES, pH 7.5, 100 mM KCl, 2.5–300 mM NaCl, 
1 µM valinomycin, and 1 µM [3H]succinate. The kinetic parame-

















where V is the initial rate, [S] is the substrate concentration (the 
concentration of the co-substrate is kept constant), and b is the 
Hill coeficient.
For the succinate dose–response curve (Fig. 6 A), the kinetic 
parameters were derived by itting the data with the Hill equation 
and Michaelis–Menten equation:
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transport of succinate to both Na+ and Li+ (at a concen-
tration of 5 mM), but not K+ (Mancusso et al., 2012). As 
noted, we observed rapid accumulation of succinate upon 
the application of an inwardly directed Na+ (Fig. 2 A, 
closed circles). Replacing Na+ with Li+ results in measurable 
established by Lévy et al. (1992). SDS-PAGE analysis of 
the resulting proteoliposomes revealed a single band at 
the same molecular weight as the protein puriied in 
detergent solution (Fig. 1), conirming incorporation 
of the protein. Given the results of cell-based assays 
(Mancusso et al., 2012), we initially assessed function by 
measuring succinate uptake in our reconstituted system. 
Upon the application of an inwardly directed Na+ gradi-
ent (100 mM outside, 1 mM inside), we observed rapid 
accumulation of the radiolabeled succinate into the 
lumen of the proteoliposomes (Fig. 2 A, closed circles). 
Under the same conditions, we found no accumulation 
of substrate for protein-free liposomes (not depicted), 
demonstrating that, as expected, VcINDY is responsi-
ble for catalyzing succinate transport. VcINDY-contain-
ing proteoliposomes did not accumulate substrate in 
the presence of equimolar concentrations of Na+ on 
both sides of the membrane, revealing that a Na+ gradi-
ent is required for succinate transport (Fig. 2, A and B, 
open triangles).
Cation speciicity of succinate transport by VcINDY
All currently characterized members of the DASS family 
of transporters use an electrochemical Na+ gradient to 
power transport of their respective substrates, with the 
exception of ly DrINDY and a vacuolar homologue 
from Arabidopsis (AttDT), both of which are cation 
independent (Inoue et al., 2002a; Knauf et al., 2002; 
Emmerlich et al., 2003). Li+ has been shown to substitute 
for Na+ in transport in some cases or to actually inhibit 
transport in others, with the best example of this being 
the rat and human orthologues of NaCT; the former is 
inhibited, whereas the latter is capable of Li+-driven 
transport (Inoue et al., 2003). Previous whole cell trans-
port assays suggest that VcINDY can eficiently couple 
Figure 1. Puriication and reconstitution of 
VcINDY. Crystal structure of VcINDY (Protein 
Data Bank accession no. 4F35) viewed from (A) 
within the plane of the membrane and (B) per-
pendicular to the membrane on the periplasmic 
side. One protomer is colored white, and the 
other is blue. The position of the bound citrate 
(pink spheres) and Na+ ions (green spheres) is 
shown. (C) SDS-PAGE analysis of VcINDY after 
immobilized metal afinity chromatography pu-
riication (Detergent) and reconstitution into 
liposomes (Proteoliposomes). The band corre-
sponding to VcINDY is labeled. Standard mo-
lecular weights (M) are indicated on the left of 
the gel.
Figure 2. Cation speciicity of VcINDY transport. (A) Transport 
of [3H]succinate into VcINDY-containing liposomes in the pres-
ence of an inwardly directed Na+ gradient (closed circles), Li+ 
gradient (open circles), and K+ gradient (closed triangles), or 
symmetrical [Na+] (open triangles). (B) The same data as in A, 
but with the Na+ gradient data removed to expand the scale and 
highlight Li+-driven transport.
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should increase the initial succinate transport rate (given 
the lack of K+ dependence of transport). Indeed, the 
addition of valinomycin resulted in a 2.5-fold increase 
in the initial rate of succinate transport, demonstrating 
that transport by VcINDY is electrogenic (Fig. 4 A). Fur-
thermore, setting the membrane potential to values be-
tween 100 and +100 mV using K+/valinomycin reveals 
variation in transport rates with the applied voltage 
(Fig. 4 B). We observed the highest transport rates at 
large negative membrane potentials, decreased rates at 
intermediate voltages, and the lowest rates at positive 
membrane potentials (Fig. 4 B). Collectively, these data 
demonstrate that transport of succinate is electrogenic 
and that at least one net positive charge is transferred 
into the liposome per transport cycle, suggesting that at 
least three Na+ ions are coupled to the transport of one 
divalent succinate molecule per transport cycle.
The exchange reaction in a transporter monitors the 
binding of substrate and the outward facing to inward 
facing transition of the protein (Mulligan and Mindell, 
2013). In theory, coupling between substrates (in a sym-
porter like VcINDY) requires that only the empty or fully 
loaded transporter should be able to eficiently exchange 
between inward-facing and outward-facing states, other-
wise coupling would be compromised (Stein, 1986). Thus, 
but vastly decreased transport that is only appreciable if 
plotted separately from the Na+-dependent transport 
(Fig. 2 B, open circles). This result is surprising consid-
ering the above in vivo transport data that suggest al-
most equal eficacy of the two cations (Mancusso et al., 
2012). Note though that those experiments were at much 
lower [Li+] than ours, and that strong concentration de-
pendence of transport to Li+ has been observed previ-
ously for other SLC13 proteins (Pajor, 2006). A K+ gradient 
is incapable of supporting transport via VcINDY (Fig. 2 B, 
closed triangles).
Na+ dependence of succinate transport
The number of Na+ ions coupled to transport varies 
among the members of the DASS family; most couple 
the transport of their respective substrate to three Na+ 
ions (Busch et al., 1994; Kekuda et al., 1999; Wang et al., 
2000; Dawson et al., 2005; Miyauchi et al., 2006), whereas 
some couple transport to two Na+ ions (Markovich et al., 
2005; Hall and Pajor, 2007; Pajor et al., 2013), and some 
to four (Inoue et al., 2002c). We investigated the num-
ber of Na+ ions coupled to succinate transport by VcINDY 
by monitoring the transport rate of [3H]succinate in 
the presence of varying external concentrations of Na+. 
The succinate transport rate depends strongly on the 
external Na+ concentration (Fig. 3). At 30°C, kinetic analy-
sis revealed an apparent Km for Na+ of 41.7 ± 2.6 mM, a 
Vmax of 53.5 ± 7.2 nmol/mg/min, and a Hill coeficient 
of 3.2 ± 0.3 (at 1 µM succinate), suggesting that three or 
more Na+ ions are coupled to the transport of one suc-
cinate molecule. If indeed VcINDY couples the trans-
port of one succinate to three (or more) Na+ ions, we 
would expect net positive charge movement across the 
membrane during the transport cycle. The ensuing 
generation of an inside-positive membrane potential 
would inhibit further transport of [3H]succinate. Under 
these circumstances, if a rate-limiting step in transport 
is voltage dependent, dissipation of this voltage using 
the K+ ionophore valinomycin in the presence of K+ 
Figure 3. Na+ dependence of [3H]succinate transport activity. 
Initial rates of [3H]succinate transport as a function of external 
Na+ concentration. A triplicate dataset is averaged (error bars rep-
resent SEM) and it to the Hill equation.
Figure 4. Electrical properties of VcINDY transport. (A) Trans-
port of [3H]succinate into VcINDY-containing liposomes in the 
presence of an inwardly directed Na+ gradient in the presence 
(open circles, +Val) and absence (closed circles, Val) of valino-
mycin. (B) Modulation of Na+-dependent [3H]succinate trans-
port as a function of the voltage across the membrane set with 
K+/valinomycin. Data are from triplicate datasets, and the error 
bars represent SEM.
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single succinate-binding site per protomer. The param-
eters of the it include apparent Km of 1.0 ± 0.2 µM, Vmax 
of 232.6 ± 17.2 nmol/mg/min, and a Hill coeficient of 
0.88 ± 0.13 (30°C and a [Na+] of 100 mM), and a turn-
over rate (Kcat) of 1.6 min1. This number represents a 
lower limit for the actual turnover rate but is accurate if 
all protein added to the reconstitution is active and is 
incorporated into liposomes and the vesicles are tight 
(Fig. 6 A). Collectively, these results are consistent with 
the presence of a noncooperative succinate-binding site 
and hint that the motions of the two protomers compris-
ing the dimer are, to a irst approximation, independent 
of one another.
Previous characterization of a few candidate VcINDY 
substrates suggests that the transporter is capable of trans-
porting succinate and at least interacting with malate 
and fumarate (Mancusso et al., 2012). Citrate confers 
enhanced thermostability (compared with the presence 
of no substrate) and is thought to be responsible for the 
electron density in the binding site of the crystal struc-
ture (Mancusso et al., 2012). We explored the substrate 
speciicity of VcINDY using a competition assay in which 
we measured the transport of 1 µM [3H]succinate in the 
presence of excess concentrations (1 mM) of 29 candi-
date substrates (Fig. 6 B). We observed strong inhibition 
of succinate transport in the presence of the C4-darboxy-
lates: succinate, malate, fumarate, and oxaloacetate 
(Fig. 6 C); succinate derivatives: 2,3-dimercaptosuccinate 
and mercaptosuccinate (but, interestingly, not 2,3-dimethyl-
succinate); and the C5-dicarboxylate: -ketoglutarate. 
The binding site is clearly sensitive to the length of the 
carbon chain as neither shorter (oxalate (C2) and malo-
nate (C3)) nor longer (glutarate (C5), adipate (C6), pimel-
ate (C7), and suberate (C8)) dicarboxylates substantially 
inhibit succinate transport (Fig. 6 B). Maleate, the cis 
isomer of trans-butenedioic acid, has no inhibitory effects, 
unlike the trans isomer fumarate, showing that the trans-
porter is isomer selective, a characteristic shared by 
other DASS members (Kekuda et al., 1999; Wang et al., 
2000; Inoue et al., 2002a,c; Fei et al., 2003). We observe 
no inhibition by known substrates of NaS1 or NaS2 fami-
lies: sulfate, selenate, thiosulfate, or dimercaptopropane-1- 
sulfonate (Busch et al., 1994; Markovich et al., 2005). 
Nor do we ind effective inhibition of succinate trans-
port by aspartate or glutamate, both of which interact 
with several DASS family members (Chen et al., 1998; 
Kekuda et al., 1999; Pajor and Sun, 2000; Wang et al., 
2000; Strickler et al., 2009; Pajor et al., 2013). Inhibition 
of succinate transport implies an interaction between 
the transporter and the potential substrate. Although 
an alternative mechanism for inhibition, such as alloste-
ric regulation, cannot be excluded based on this simple 
assay, the chemical similarity of the above candidates to 
succinate makes a competitive inhibition mechanism 
seem likely. Furthermore, this experiment does not 
allow us to discriminate between the inhibitors acting 
the exchange reaction should require both coupled ions 
and substrate (the empty transporter, of course, will not 
mediate exchange of anything). We tested this predic-
tion for VcINDY using a solute counterlow assay to mon-
itor succinate exchange in the presence and absence of 
equimolar [Na+] across the membrane (substituting with 
the nontransportable cation, choline). In this assay, the 
proteoliposomes are irst loaded with a high concentra-
tion of unlabeled substrate and then diluted into an 
external solution containing a trace amount of [3H]suc-
cinate. Stochastic, alternate sampling of the substrate-
binding site to both sides of the membrane results in 
exchange of unlabeled substrate on the inside for radio-
labeled substrate on the outside, resulting in uptake of 
the labeled substrate even without net change in its con-
centration (Kaczorowski and Kaback, 1979). In the pres-
ence of 100 mM Na+ on both sides of the membrane, 
VcINDY catalyzes accumulation of [3H]succinate (Fig. 5). 
However, we observe no exchange activity when Na+ is 
replaced with choline. This result underscores the tight 
coupling of transport and supports a model where both 
Na+ and succinate are simultaneously bound during 
substrate translocation, consistent with suggestions from 
the VcINDY crystal structure. Notably, a previously char-
acterized bacterial orthologue of VcINDY, SdcS from 
Staphylococcus aureus, reportedly catalyzes Na+-indepen-
dent exchange of its substrate across the membrane, 
despite also being a Na+ gradient–driven transporter 
(Hall and Pajor, 2007). If supported by further experi-
ments, this inding may yield insight into the nature of 
the coupling mechanism.
Substrate speciicity and kinetics of VcINDY
To explore the interaction between VcINDY and succi-
nate, we monitored the succinate dose dependence of 
the initial transport rates in the presence of saturating 
(100 mM) concentrations of Na+ (Fig. 6 A). This rela-
tion is well-it by a hyperbolic curve, consistent with a 
Figure 5. Solute counterlow activity of VcINDY. Solute coun-
terlow activity of VcINDY-containing liposomes in the presence 
(closed circles, +Na+) and absence (open squares, Na+) of Na+. 
Data are from triplicate datasets, and the error bars represent 
SEM.
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as expected, not transported by VcINDY. In this experi-
ment, fumarate showed the highest initial rate of up-
take, followed by succinate/oxaloacetate then malate. 
Thus, VcINDY can catalyze the transport of several re-
lated dicarboxylate-containing compounds.
We also tested the inhibitory effect of several known 
DASS family inhibitors. Benzylpenicillin, which inhibits 
a NaDC3 homologue from winter lounder (Burckhardt 
et al., 2004), elicits no response when added to the 
transport reaction. Folate, although itself not a substrate 
of NaDC3, can modulate succinate-derived transport 
current (Burckhardt et al., 2005); in our hands, folate 
had a modest inhibitory effect on VcINDY transport. 
Flufenamic acid yields substantial inhibition of VcINDY 
transport (Fig. 6 B). This compound noncompetitively 
by competitively binding to VcINDY versus being trans-
ported by the protein.
To establish which of these act as substrates and 
which merely inhibit the transport process, we evalu-
ated several of these compounds for substrate activity 
by performing counterlow assays: loading vesicles with 
the candidate compound and diluting them into buffers 
containing small amounts of radiolabeled succinate. In 
these experiments, accumulation of radiolabeled succi-
nate will only occur if VcINDY can transport the can-
didate compound. The results of this experiment are 
shown in Fig. 6 D. Clearly, VcINDY can transport fuma-
rate, oxaloacetate, and malate, which, as shown above, 
are the most effective inhibitors of succinate transport. 
Gluconate, which did not inhibit succinate transport, is, 
Figure 6. Substrate interactions with VcINDY. (A) Initial rates of [3H]succinate transport as a function of external succinate concen-
tration. The data are it to the Michaelis–Menten equation. (B) Substrate speciicity of VcINDY. Initial transport rate of [3H]succinate 
into VcINDY-containing proteoliposomes in the presence of an inwardly directed Na+ gradient at pH 7.5 and 29 potential substrates. 
Data for each competitor were normalized to the transport rate in the absence of competitor compound. OAA, oxaloacetate; -KG, 
-ketoglutarate; 2,3-DMS, 2,3-dimethylsuccinate; 2,3-DMAS, Meso-2,3-dimercaptosuccinate; DMAPS, dimercaptopropane-1-sulfonate; 
MAS, mercaptosuccinate. All data presented are the average from triplicate datasets, and the error bars represent SEM. (C) Chemical 
structures of the four most effective inhibitors: succinate, malate, fumarate, and oxaloacetate. (D) Solute counterlow activity of VcINDY-
containing liposomes in the presence of 1-mM lumenal concentration of the most effective inhibitors identiied in B: succinate (closed 
circles), malate (open circles), fumarate (closed triangles), and oxaloacetate (open triangles). Gluconate (open squares) is included as 
a negative control. All data presented are the average from triplicate datasets, and the error bars represent SEM.
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which (in this range) matches exactly the decrease in 
the relative abundance of fully deprotonated succinate 
(Fig. 7 A, Succ2, gray line), suggesting that Succ2 is 
the actual substrate of VcINDY. At lower pHs (4–5), the 
correlation between succinate accumulation rates and 
relative abundance of fully deprotonated succinate di-
verges with more substrate accumulating in the lipo-
somes than predicted by the titration curve (Fig. 7 A). 
What is the cause of this divergence? One possibility is 
that there is proton-driven transport that is only observ-
able at low pHs, which is unlikely given the lack of gradi-
ent dependence at higher pH. Alternatively, there could 
be a relative increase in the abundance of the mono-
protonated and fully protonated states of succinate 
(SuccH1 and SuccH2, respectively); at low pH, both of 
these, particularly the neutral form, are known to tra-
verse the lipid bilayer itself (Kaim and Dimroth, 1998, 
1999; Janausch et al., 2001). Upon internalization, the 
higher internal pH in the liposomes (7.5) would fully 
deprotonate SuccH1 and SuccH2, trapping them and 
resulting in their accumulation. We tested this hypoth-
esis by monitoring accumulation of [3H]succinate into 
protein-free liposomes with an internal pH of 7.5 and 
varying the external pH between 4 and 7.5 (Fig. 7 D). At 
low external pH values, we observed substantial accu-
mulation of succinate, accumulation that increased as the 
external pH decreased. This result validates the second 
hypothesis that the deviation from predicted transport 
inhibits both eukaryotic and bacterial DASS members 
(Burckhardt et al., 2004; Pajor and Sun, 2013), suggesting 
that the binding site for this particular inhibitor is pre-
served, despite the evolutionary distance between these 
transporters. Tricarballylate, a tricarboxylate similar 
in structure to citrate, inhibits transport. Citrate itself, 
however, does not inhibit transport at 1 mM under these 
conditions (Fig. 6 B, although see below for further as-
sessment of high citrate concentrations).
pH dependence of succinate transport
Determining the charged state of the transported sub-
strate is a key step in understanding the mechanism of 
VcINDY. Whether the substrate is neutral, singly, or dou-
bly charged (or more than one of these) will affect the 
ability of the succinate to coordinate cotransported cat-
ions, inluence the pH dependence of the transporter, 
and inluence the coupling of transport to the membrane 
potential (via the net charge movement per transport 
cycle). Because succinate is a dicarboxylic acid with 
pKas within the range of pHs tested (4.21 and 5.64), the 
relative abundance of each protonation state of succi-
nate varies with pH (Fig. 7, A–D, solid lines). By examin-
ing transport rates at varying external pHs, we can 
thereby control, to some extent, the relative fractions of 
the three charged forms of the substrate. While main-
taining a pHINT of 7.5, we observe that decreasing the 
pHEXT from 7.5 to 5.5 decreases the transport rate, 
Figure 7. pH dependence of [3H]succinate transport by VcINDY. The black bars represent the initial accumulation rates of [3H]succi-
nate into VcINDY-containing liposomes (A–C) and protein-free liposomes (D) under the following conditions: (A and D) ixed internal 
pH 7.5 and variable external pH, (B) symmetrical variation of pH, and (C) variable internal pH and ixed external pH 7.5. The line 
graphs represent the theoretical percentage of abundance of each protonation state of succinate (gray, deprotonated; red, monoproton-
ated; green, fully protonated) across the pH range used (percentage of abundance was calculated using HySS software; Alderighi et al., 
1999). Below each panel is a schematic representation of the experimental conditions used; the thick black line represents the bilayer, 
the blue shapes represent VcINDY, and the internal and external pHs are noted. The orange and purple arrows indicate the presence 
of inwardly directed succinate and Na+ gradients, respectively. All data presented are the average from triplicate datasets, and the error 
bars represent SEM.
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tested (Fig. 8 C, closed circles). At pH 5.5, where the 
dianionic form of citrate is most abundant, we observed 
no inhibitory effects of citrate at 10 mM; however, in-
creasing the citrate concentration to 25 mM resulted in 
60% inhibition of succinate transport (Fig. 8 C, open 
rates is caused by direct membrane permeability of at 
least the neutral form of succinate and possibly its singly 
charged form as well. Indeed, the effects of the per-
meable succinate protonation states are also seen with 
ixed external pH 7.5 and varying internal pH. Although 
we observed robust transport at the higher internal pH, 
lowering the internal pH favored the membrane-per-
meant species and they diffused out of the liposomes, 
manifesting as an apparent lack of transport (Fig. 7 C). 
These results clearly demonstrate that only the doubly 
charged protonation state of succinate is transported by 
VcINDY. Our pH dependence experiments also reveal 
that VcINDY transport of succinate is not coupled to a 
proton gradient because the pH dependence of trans-
port is essentially identical in the absence (Fig. 7 B) or 
presence of an inwardly directed (Fig. 7 A) or outwardly 
directed (Fig. 7 C) pH gradient (when we neglect the 
effects of direct succinate bilayer permeability).
Investigating the interactions between VcINDY and citrate
In our substrate competition assay, we observed no in-
hibition of succinate transport in the presence of 1 mM 
citrate (Fig. 6 B), a surprising result given the presumed 
citrate density in the crystal structure and the stabilizing 
effect of the ion on the folded protein (Mancusso et al., 
2012). Comparing our transport conditions to those of 
crystallization, we found that the VcINDY was crystal-
lized (in 100 mM citrate) at pH 6.5, whereas our compe-
tition assay was performed at pH 7.5. At pH 7.5, citrate 
is predominantly in its deprotonated state, citrate3, 
whereas at pH 6.5, half the citrate is citrate3, whereas 
the other half is citrateH2 (Fig. 8 A, green and yellow 
block colors, respectively). Perhaps VcINDY only binds 
doubly charged anions, as we demonstrated is the case 
with succinate, which would explain why we observed 
no inhibition by citrate at pH 7.5 where the citrateH2 
protonation state is scarce. To test this, we monitored the 
transport of succinate in the presence of excess (1 mM) 
citrate at pH 7.5, 6.5, and 5.5. At pH 7.5, both succinate 
and citrate were almost fully deprotonated (Fig. 8 A, 
block colors, citrate; line data, succinate). At pH 6.5, 
however, a large population of citrate was dianionic and 
the majority of succinate was still deprotonated. At 
pH 5.5, 80% of the citrate will be dianionic, whereas 50% 
of the deprotonated succinate will remain. If citrateH2 
binds and inhibits succinate transport by VcINDY, then 
lowering the pH should lead to observable inhibition. 
At the three different pH values, we observed no inhibi-
tory effects of citrate on succinate transport, indicating 
that at this citrate concentration (1 mM), neither 
citrate3 nor citrateH2 interacts with VcINDY (Fig. 8 B). 
We investigated whether citrate simply binds at much 
lower afinity, by measuring succinate transport in the 
presence of increasing external concentrations of citrate. 
At pH 7.5, we observed 25% inhibition of transport ac-
tivity at 75 mM citrate, the highest concentration we 
Figure 8. Citrate speciicity of VcINDY. (A) Theoretical per-
centage of abundance of the protonation states of citrate (block 
colors: green, deprotonated; yellow, monoprotonated; orange, 
diprotonated; red, fully protonated) and succinate (lines: blue, 
deprotonated; purple, monoprotonated; black, fully protonated) 
as a function of pH (percentage of abundance was calculated 
using HySS software; Alderighi et al., 1999). (B) Normalized ini-
tial rate of succinate (inal concentration of 1 µM with a radiola-
beled to unlabeled ratio of 1:9) transport at pH 7.5, 6.5, and 5.5 
in the presence (+) and absence () of 1,000-fold excess (1 mM) 
of citrate. (C) Initial rates of [3H]succinate transport at pH 7.5 
(closed circles) and 5.5 (open circles) as a function of citrate con-
centration. Data are from triplicate datasets, and the error bars 
represent SEM.
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its position on the protein, can be exposed to either 
side of the membrane. These data reveal that the VcINDY 
protein incorporates in the liposome membrane in 
both possible orientations. Although our data are not 
quantitative enough to accurately determine the relative 
proportions of these orientations, they are consistent 
with a roughly equal distribution of both. In this con-
text, our results on citrate inhibition are at least consis-
tent with a sided mechanism of inhibition.
Does VcINDY have an uncoupled chloride conductance?
The VcINDY protomer is composed of two distinct do-
mains: the scaffold domain, which forms all of the contacts 
at the dimer interface, and the transport domain, which 
houses all of the substrate-binding residues (Mancusso 
et al., 2012). This architecture is reminiscent of the EAAT 
homologue, GltPh, whose structure and mechanism have 
been well studied (Yernool et al., 2004; Reyes et al., 
2009; Hänelt et al., 2013; Jensen et al., 2013). During its 
transport cycle, GltPh undergoes an elevator-type move-
ment of the transport domain relative to the immobile 
scaffold domain (known as the trimerization domain in 
GltPh), exposing the binding site from one side of the 
membrane to the other. Because of the architectural 
similarity between VcINDY and GltPh, there is a possibility 
circles). Further increases in citrate concentration did 
not result in further inhibition (Fig. 8 C). Increased in-
hibition by citrate at the lower pH suggests that citrateH2 
does indeed interact with VcINDY, albeit with low afin-
ity. Why do we see 40% residual transport activity? If 
citrate is a competitive inhibitor that binds to VcINDY at 
the same site as succinate, one would expect complete 
inhibition of VcINDY transport activity upon adding suf-
icient excess of the ion. The fact that we do not see 
complete inhibition has a potentially simple explana-
tion; if, as has been suggested (Mancusso et al., 2012), 
citrate is an inward-facing state-speciic inhibitor of 
VcINDY, then its inhibitory eficacy would be depen-
dent on the orientation of VcINDY in the membrane. If 
the orientation of VcINDY in the liposomes is mixed, 
i.e., VcINDY is present in the membrane in two popula-
tions, outside out (as it is oriented in vivo) and inside 
out, then citrate would only affect the population of 
VcINDY with its inner façade facing outward.
We addressed this issue by determining the orientation 
of VcINDY in the liposome membrane. We introduced 
single-cysteine residues into a cysteine-less version of 
VcINDY (cysless, each native cysteine was mutated to 
serine) at positions on either the cytoplasmic (A171C) 
or extracellular (V343C) faces of the protein (Fig. 9 A). 
Cysless VcINDY and the two single-cysteine mutants 
displayed measurable transport activity upon reconsti-
tution into liposomes (Fig. 9 B). Because our luores-
cent probe is somewhat membrane permeant (not 
depicted), we designed a multistep protocol to estab-
lish protein orientation. We treated all three mutants 
with the membrane-impermeable thiol-reactive reagent 
MM(PEG)12, solubilized the membrane, and labeled 
the remaining cysteines with the thiol-reactive luoro-
phore Alexa Fluor 488–maleimide. We analyzed the ex-
tent of labeling by separating the proteins using PAGE 
and imaging the gels while exciting the luorophore 
with UV transillumination. Thus, only cysteine residues 
facing the lumen of the proteoliposomes, protected 
from MM(PEG)12 labeling, should be luorescently la-
beled. The reactivity pattern of the two single-cysteine 
mutants suggests that VcINDY adopts a mixed orienta-
tion in the membrane (Fig. 9 C). First, both the internal 
site (V171C) and the external site (A343C) exhibited 
luorescent labeling (Fig. 9 C, lane 1 for each mutant), 
indicating that both cysteines, despite being on opposite 
faces of the protein, were at least partially protected from 
MM(PEG)12 modiication before membrane solubili-
zation. Solubilizing the membrane before MM(PEG)12 
labeling resulted in no luorescent labeling (Fig. 9 C, 
lane 2); therefore, we are indeed luorescently labeling 
the internally located cysteines. Second, excluding the 
MM(PEG)12 labeling step, solubilizing the membrane, 
and luorescently labeling all available cysteines resulted 
in substantially greater luorescent labeling (Fig. 9 C, 
lane 3), demonstrating that each cysteine, regardless of 
Figure 9. Determining the orientation of reconstituted VcINDY. 
(A) Structure of a single VcINDY protomer and its predicted po-
sitioning relative to the membrane. The positions of the external 
cysteine (V343C) and the internal cysteine (A171C, red spheres) 
are shown, as well as the bound citrate (pink spheres) and Na+ ion 
(green sphere). (B) Initial transport rates of [3H]succinate in the 
presence of an inwardly directed Na+ gradient and liposomes con-
taining wild-type VcINDY, cysteine-free VcINDY (cysless), VcIN-
DYA171C, and VcINDYV343C. (C) Coomassie staining (top) and 
Alexa Fluor 448 labeling (bottom) of proteoliposomes containing 
the VcINDY mutants cysless, VcINDYA171C, and VcINDYV343C, 
treated as follows: (1) MM(PEG)12 treatment followed by solubi-
lization and Alexa Fluor 448–maleimide treatment; (2) solubili-
zation, MM(PEG)12 treatment, and Alexa Fluor 448–maleimide 
treatment; or (3) solubilization followed by Alexa Fluor 448-ma-
leimide treatment.
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potential with the ionophore does not compensate for 
the absence of Cl. This, in turn, suggests that Cl is not 
itself dissipating the potential; it is not free to move 
across the membrane. This contrasts strongly with the 
observations reported for GltPh, where the addition of 
valinomycin fully compensates for the inhibition caused 
by Cl replacement (Ryan and Mindell, 2007). Although 
the picture is somewhat clouded by the mild inhibition 
caused by methanesulfonate, these data suggest that the 
inhibition observed in the absence of valinomycin is 
caused by the presence of methanesulfonate rather 
than by the absence of chloride. This result therefore 
indicates that VcINDY does not have an uncoupled 
chloride conductance. However, it does further demon-
strate that VcINDY is capable of interacting with several 
structurally unrelated anions.
D I S C U S S I O N
The crystal structure of VcINDY represents the only high 
resolution structural information available for the DASS 
family of transporters. This study reports on the func-
tional reconstitution and characterization of VcINDY to 
establish which transport features it shares with other 
DASS family members, including the physiologically im-
portant SLC13 family from humans. A detailed under-
standing of the transport mechanism of VcINDY will 
allow us to begin to understand the functional charac-
teristics of other DASS family members from a struc-
tural viewpoint.
In accordance with the majority of functionally char-
acterized DASS family members, VcINDY uses an elec-
trochemical Na+ gradient to power transport of the 
model substrate, succinate. A Li+ gradient can substitute 
for the Na+ gradient at 100 mM, but with a much lower 
relative eficacy compared with what was seen in cell-
based assays at 5 mM Li+ (Mancusso et al., 2012). This 
observed disparity between cell-based and liposome-
based assays is likely caused by complications that arise 
from measuring transport in whole cells where the in-
ternal solution composition is hard to control and there 
are unknown contributions from endogenous trans-
porters, as opposed to a puriied and reconstituted sys-
tem where a single protein is present and altering and 
maintaining the reaction solutions is trivial. The struc-
ture of VcINDY suggests a single substrate-binding site 
per protomer (Mancusso et al., 2012). This assertion is 
corroborated by kinetic analysis of succinate transport 
that revealed a hyperbolic dose–response curve and a 
Hill coeficient of 0.88, consistent with a single, nonco-
operative binding site for succinate. Under similar ex-
perimental conditions, although performed in whole 
cell assays or in membrane vesicles, two related bacte-
rial transporters, SdcF and SdcS (30 and 32% identical 
to VcINDY, respectively), have sigmoidal dose–response 
curves, indicative of cooperative transport activity (Pajor 
that they share a similar mode of action, namely, an ele-
vator-type mechanism. A characteristic of the EAATs and 
GltPh is the presence of an uncoupled anion conduc-
tance, the pathway of which has been proposed to be 
located at the interface between the transport domain 
and the scaffold (Ryan and Mindell, 2007; Verdon and 
Boudker, 2012). If an uncoupled Cl conductance is a 
consequence of an elevator-like mechanism, this uncou-
pled anion conductance may also be shared. Several other 
DASS family members have been shown to exhibit inter-
esting traits in the presence of anions, although not 
necessarily suggestive of an uncoupled chloride con-
ductance (Inoue et al., 2002a; Oshiro and Pajor, 2005).
As we described previously, VcINDY-mediated transport 
of succinate is electrogenic: transport is enhanced by 
dissipating the membrane potential, as by valinomycin 
in Fig. 4. If VcINDY also carries an uncoupled Cl con-
ductance, then Cl ion would also aid in dissipating the 
membrane potential, serving a role similar to that of val-
inomycin and thereby facilitating transport. In this case, 
replacing Cl with an impermeant anion should reduce 
transport rates, but only in the absence of valinomycin 
(Fig. 4), as was the case for GltPh (Ryan and Mindell, 2007). 
We initially replaced chloride with gluconate and found, 
unexpectedly, that 100 mM gluconate is an excellent in-
hibitor of VcINDY (not depicted), despite exhibiting no 
inhibitory properties at lower concentrations (Fig. 6 B). 
We therefore substituted gluconate with another com-
monly used impermeable anion, methanesulfonate. Unfor-
tunately, even methanesulfonate mildly inhibits VcINDY 
succinate transport. However, suficient activity remains 
to evaluate the possibility of a Cl conductance. We see 
similar fractional inhibition when Cl is replaced by 
methanesulfonate in the presence or absence of valino-
mycin (Fig. 10), indicating that dissipating the membrane 
Figure 10. Chloride conductance of VcINDY. Transport of 
[3H]succinate in the presence of chloride (+Cl, gray lines; data 
from Fig. 2 is redrawn) or methanesulfonate-containing buffers 
(Cl/+MSF) in the presence (open symbols) and absence 
(closed symbols) of valinomycin. Data are it to a single-exponen-
tial rise to max. Data are from triplicate datasets, and the error 
bars represent SEM.
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of both citrate3 and succinate2 to four Na+ ions (Inoue 
et al., 2002c), and all currently characterized bacterial 
homologues. Aside from VcINDY, all other bacterial ho-
mologues cotransport two Na+ ions with succinate in an 
electroneutral process (Hall and Pajor, 2005, 2007; 
Strickler et al., 2009; Pajor et al., 2013). Of all the bacte-
rial transporters characterized to date, VcINDY is the 
most similar to the mammalian homologues in both se-
quence and function and is therefore an excellent choice 
for a bacterial model of this family.
Aside from its apparent inability to transport citrate, 
the mechanism (electrogenicity, coupling ion stoichiom-
etry) and substrate speciicity of VcINDY most resemble 
the eukaryotic DASS members NaDC1 and NaDC3. The 
primary functional distinction between NaDC1 and 
NaDC3 is their Km values; the former is considered low 
afinity, with a Km range of 300–750 µM, and the latter is 
considered high afinity, with a Km range of 2–20 µM. 
With a Km value of 1 µM (the lowest Km value reported 
for this family), VcINDY is most functionally similar to 
NaDC3 in this regard.
Our data suggests that citrate is capable of binding 
VcINDY, but only in its dianionic form and possibly only 
to one side of the protein. The irst part of this conclu-
sion is based on the observation that succinate transport 
is mainly affected by the presence of citrate at pH 5.5, 
where the majority of the citrate is dianionic, as op-
posed to pH 7.5, where the citrate3 is the predominant 
protonation state. In keeping with this, the crystal struc-
ture of VcINDY was captured at pH 6.5, where a large 
proportion of the 50 mM citrate present would be dian-
ionic and therefore available to bind (Mancusso et al., 
2012). However, inconsistent with this proposition is 
the observation that citrate confers considerable ther-
mostability to VcINDY in pH 8.0 conditions, where only 
a small proportion of the citrate would be dianionic 
(Mancusso et al., 2012). This stabilizing effect may 
be explained by an allosteric interaction with citrate, 
but further work will be required to resolve this issue. 
Based on the crystal structure alone, citrate was pro-
posed to be an inward-facing state inhibitor of VcINDY 
(Mancusso et al., 2012). Our results are consistent with 
this claim: we observed maximal inhibition of 50% re-
gardless of how high we increased the citrate concen-
tration, and we also demonstrate that the orientation of 
VcINDY in the liposomes is mixed. Further work is re-
quired to fully elaborate on the interaction between 
VcINDY and citrate. To date, VcINDY is the only bacte-
rial DASS member to demonstrably interact with citrate 
(Hall and Pajor, 2005, 2007; Youn et al., 2008; Strickler 
et al., 2009; Pajor et al., 2013). The observed interaction 
with citrate2, although not actual transport, further 
strengthens the functional similarity between VcINDY 
and NaDC1 and NaDC3, both of which transport citrate 
and prefer the doubly charged form (Kekuda et al., 
1999; Wang et al., 2000). NaCT, on the other hand, 
and Sun, 2013; Pajor et al., 2013). This inding suggests 
that either two substrate molecules bind to the same 
protomer, a notion inconsistent with our current struc-
tural understanding of this transporter family, or that 
the two protomers in a VcINDY dimer act cooperatively. 
Again, this observed sigmoidal activity may be a conse-
quence of using whole cells and membrane vesicles in 
transport assays, as opposed to the puriied and recon-
stituted system. Adding weight to this argument is the 
observation that puriied and reconstituted SdcS has a Hill 
coeficient of 0.83, which is more in keeping with the ap-
parently noncooperative transport we observe for VcINDY 
(Hall and Pajor, 2007). Although subunits in different 
DASS proteins may interact differently, our work points to 
each VcINDY protomer working independently.
The transport data presented here are inconsistent 
with a H+ gradient contributing to transport; however, 
we found transport of succinate to be highly pH depen-
dent. This mirrors the observations of pH-dependent 
transport for NaDC1 in whole cells (Wright et al., 1982). 
The decrease in succinate transport as pH dropped cor-
responds almost perfectly with the decrease in the theo-
retical abundance of succinate2 at higher pH, strongly 
suggesting that succinate2 is the actual substrate of 
VcINDY. In contrast, succinate transport by NaDC1 was 
completely insensitive to the solution pH, suggesting that 
the monoprotonated and deprotonated forms of succi-
nate may both be transported (Pajor, 1995). NaDC3, 
however, is highly pH dependent, showing clearly that 
succinate2 is the only succinate protonation state trans-
ported (Kekuda et al., 1999). Of the other bacterial 
DASS members where the pH dependence of succinate 
transport has been studied, SdcL from Bacillus licheniformis 
was insensitive to pH (although the pH range tested was 
limited) (Strickler et al., 2009), and SdcS was sensitive, 
demonstrating that succinate2 is the preferred sub-
strate here as well (Hall and Pajor, 2005). The proton-
ation state of the substrate has profound effects on the 
transport mechanism, as it is fundamentally linked to 
the number of coupling ions transported and the elec-
trogenicity of the transporter. The observation that 
succinate2 is the preferred protonation state, coupled 
with the fact that transport by VcINDY was electrogenic, 
demonstrates that at least three Na+ ions are coupled to 
the transport of one succinate2. This stoichiometry is 
corroborated by kinetic analyses of both succinate and 
Na+ dose–response curves that revealed Hill coeficients 
of 0.88 and 3.2, respectively. Although strictly these re-
sults establish three as the lower limit of the number of 
Na+ ions, we suggest that the coupling stoichiometry is 
indeed three, consistent with the Hill coeficient and by 
analogy to other coupled transporters. Almost all of the 
DASS family members have a substrate/coupling ion 
stoichiometry of 1:3 (Busch et al., 1994; Chen et al., 
1998; Kekuda et al., 1999; Miyauchi et al., 2006). The 
two exceptions are NaCT, which couples the transport 
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structural insight gained from this bacterial transporter 
and the function of its eukaryotic counterparts. Our re-
sults are also essential prerequisites for any computa-
tional examinations of binding or transport in VcINDY. 
This work demonstrates that many of the functional 
properties of mammalian DASS family members are 
retained in VcINDY, making it an excellent model for 
future structural and mechanistic studies on this family 
of transporters.
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